Medical Device News Magazine

Trelleborg Receives Patent for Dartex Zoned Coatings

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

The Trelleborg Engineered Coated Fabrics manufacturing facility in Nottingham, England, has received a patent for its Dartex Zoned Coatings®.

Dartex Zoned Coatings® uniquely offer the ability to ‘zone’ different polyurethane coatings on support surface covers used in healthcare and medical applications, allowing a single fabric to perform multiple functions. Inventors of patent number US 11,499,265 B2 are Richard Haxby, Technical Director and Ilias Alexandrakis, Senior Development Project Manager.

Haxby says: “Trelleborg has a long history of developing intellectual property and understands the value of investing in research to help drive innovation in its chosen industries, including healthcare and medical. Dartex Zoned Coatings® technology is revolutionary, making it possible for medical device manufacturers to develop the ultimate support surfaces.”

Alexandrakis, adds: “This is an exciting advancement for the industry. It will mean that medical device manufacturers can streamline their production processes, potentially saving money and bringing products to market more quickly.”

Using patent-pending manufacturing methods, Dartex Zoned Coatings® allows zoning of a support surface cover so that a single cover can have multiple physical and stretch properties across different zones without joins, welds or seams. They incorporate trusted Dartex® polyurethane coating technology from Trelleborg for patient comfort and quality.

The coatings are suitable for multiple healthcare and medical applications, including mattress covers (tops and encasements), moving and handling, positioning devices, specialist medical furniture, theatre tables, trollies and stretchers. Mattress covers can be zoned in harmony with the mattress core.

Find out more about Trelleborg’s Dartex Zoned Coatings® here: https://www.trelleborg.com/engineered-coated-fabrics/industries/healthcare-and-medical/healthcare-and-medical-product-range/dartex-zoned-coatings

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”